Top compounds associated with response to ANKRD26


Feature Type Standardized
Nominal ANOVA
mRNA JW-7-24-1 GDSC1000 pan-cancer AAC 0.12 6e-05
mRNA FK866 CTRPv2 pan-cancer AAC 0.15 9e-05
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 9e-05
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 9e-05
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0001
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA VX-680 CTRPv2 pan-cancer AAC 0.4 0.0001
mRNA BX-912 GDSC1000 pan-cancer AAC 0.11 0.0002
mRNA GSK1120212 CTRPv2 pan-cancer AAC -0.18 0.0002
mRNA THZ-2-102-1 GDSC1000 pan-cancer AAC 0.11 0.0002
Download CSV